Other

Roivant Sciences·Income Statement·22 metrics

Breakdown

Loading...

Metrics

Capital Expenditures

Change in Other Current Assets

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Finance Lease Principal Payments

Gain on sale of Telavant net assets

Increase (Decrease) in Accounts Payable, Trade

Accrued liabilities

Short- and long-term operating lease liabilities

Increase (Decrease) in Other Current Assets

Increase (Decrease) in Other Operating Assets and Liabilities, Net

Issuance Of Subsidiary Shares In Connection With Debt Renegotiation

Gain on litigation settlement

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Noncash Other

Operating lease right-of-use assets amortization expense

Other Noncash Income (Expense)

Payments for Repurchase of Common Stock

Payments to Acquire Property, Plant, and Equipment

Cash received from option exercises

Stock-based compensation